ArticleJournal of cosmetic dermatology2026
Enhancement of Skin Barrier Function Using DYNAMiQ Technology: A Clinical Evaluation.
Article in Journal of cosmetic dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe integrity of the skin barrier is fundamental to maintaining overall skin health, serving as the primary defense against environmental insults. Disruption of this barrier is linked to various dermatological issues, including inflammation, sensitivity, and premature aging. Therefore, technologies designed to reinforce the skin barrier and enhance moisture retention hold a significant promise for improving skin condition, resilience, and overall function.
aimsTo evaluate the restorative effect of DYNAMiQ technology on skin barrier function.
methodsThis prospective, single-center study enrolled 24 female subjects (n = 24, 26-64 years). Each subject received one DYNAMiQ treatment, with a follow-up assessment performed 7 days later. Transepidermal water loss (TEWL) was measured before treatment, immediately after, and at follow-up. Subject-reported outcomes were collected using comfort and satisfaction questionnaires, and standardized photographs were taken.
resultsTEWL increased slightly from a baseline of 11.95 ± 0.24 g/m
conclusionsDYNAMiQ technology effectively improves skin barrier function by significantly reducing TEWL. These findings are supported by high subject satisfaction and perceived hydration improvements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.